UPDATE 1-FDA approves Rockwell Medical's iron replacement drug

January 26, 2015 1:55 PM

3 0

Jan 26 (Reuters) - The U.S. Food and Drug Administration approved Rockwell Medical Inc's drug for treating iron loss in chronic kidney disease patients on dialysis, sending the company's shares up about 15 percent in premarket trading.

The drug, Triferic, replaces the 5-7 mg of iron patients tend to lose during each dialysis session.

Also read: Dow gains 100 points amid deluge of corporate news; real estate leads

Read more

To category page